Anthropic has acquired stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch that the deal had been finalized, but declined to comment on the price.
The deal comes as Anthropic continues its commitment to healthcare and life sciences, following the October announcement of Claude for Life Sciences, a tool aimed at supporting scientific researchers' discoveries.
Coefficient Bio founders Samuel Stanton and Nathan C. Frey, who previously worked in computational drug discovery at Genentech's Prescient Design, launched the startup eight months ago. Coefficient Bio was using AI to help streamline drug discovery and other biological research.
The team will consist of approximately 10 people and will join Anthropic's health and life sciences team.